Relative risk of being prescribed various medications for women compared with men (adjusted for practice, age and deprivation category), aged >75 years compared with those aged <75 years (adjusted for practice and deprivation category) and for Carstairs deprivation category 5 compared with Carstairs deprivation category 1 (adjusted for age, sex and practice)
| Women vs men | ⩾75 years vs <75 years | Carstairs deprivation category 5 vs 1 | ||
|---|---|---|---|---|
| Men | Women | |||
| CCBs, calcium-channel blockers. | ||||
| *Excluding dihydropyridines. | ||||
| †Includes quinidine, disopyramide, propafenone and flecainide. | ||||
| ‡Warfarin or aspirin or clopidogrel. | ||||
| §β-Blocker or rate limiting calcium channel blocker or digoxin. | ||||
| ¶Class 1 antiarrhythmic or amiodarone or sotalol. | ||||
| β-Blockers | 0.92 (0.78 to 1.09) | 0.55 (0.44 to 0.70) | 0.89 (0.69 to 1.16) | 0.72 (0.43 to 1.21) |
| CCBs* | 1.05 (0.91 to 1.24) | 0.51 (0.42 to 0.64) | 0.69 (0.55 to 0.87) | 0.73 (0.45 to 1.19) |
| Digoxin | 1.25 (1.07 to 1.46) | 1.41 (1.14 to 1.74) | 1.88 (1.50 to 2.37) | 1.00 (0.62 to 1.63) |
| Class I antiarrhythmics† | 1.34 (0.84 to 2.13) | 0.32 (0.15 to 0.67) | 0.14 (0.06 to 0.32) | 0.62 (0.14 to 2.82) |
| Amiodarone | 0.94 (0.74 to 1.19) | 0.73 (0.53 to 1.01) | 0.77 (0.54 to 1.03) | 1.10 (0.49 to 2.48) |
| Sotalol | 1.11 (0.80 to 1.54) | 0.60 (0.38 to 0.96) | 0.48 (0.30 to 0.79) | 0.51 (0.18 to 1.50) |
| Warfarin | 0.82 (0.70 to 0.96) | 0.74 (0.60 to 0.91) | 0.58 (0.46 to 0.73) | 1.21 (0.75 to 1.96) |
| Aspirin | 0.93 (0.80 to 1.08) | 2.04 (1.66 to 2.51) | 1.79 (1.42 to 2.25) | 0.78 (0.48 to 1.26) |
| Any antithrombotic | 0.85 (0.70 to 1.03) | 1.81 (1.40 to 2.35) | 1.11 (0.85 to 1.45) | 1.11 (0.61 to 2.03) |
| Negative chronotropes§ | 1.28 (1.08 to 1.51) | 0.90 (0.72 to 1.12) | 1.33 (1.03 to 1.72) | 0.97 (0.56 to 1.70) |
| Any antiarrhythmic¶ | 1.03 (0.85 to 1.24) | 0.62 (0.48 to 0.81) | 0.52 (0.39 to 0.70) | 0.80 (0.42 to 1.50) |